150 related articles for article (PubMed ID: 10910834)
1. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure.
Schroeder RA; Wood GL; Plotkin JS; Kuo PC
Anesth Analg; 2000 Aug; 91(2):291-5. PubMed ID: 10910834
[TBL] [Abstract][Full Text] [Related]
2. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
3. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
Muzaffar S; Shukla N; Angelini GD; Jeremy JY
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):949-50. PubMed ID: 15573083
[No Abstract] [Full Text] [Related]
4. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
[No Abstract] [Full Text] [Related]
5. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
6. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.
Jerath A; Srinivas C; Vegas A; Brister S
Anesth Analg; 2010 Feb; 110(2):365-9. PubMed ID: 19933533
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension.
Ocal A; Kiriş I; Erdinç M; Peker O; Yavuz T; Ibrişim E
Tohoku J Exp Med; 2005 Sep; 207(1):51-8. PubMed ID: 16082155
[TBL] [Abstract][Full Text] [Related]
8. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
9. Management of pulmonary hypertension and right ventricular failure: another step forward.
Vlahakes GJ
Ann Thorac Surg; 1996 Apr; 61(4):1051-2. PubMed ID: 8607653
[No Abstract] [Full Text] [Related]
10. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.
Haraldsson s A; Kieler-Jensen N; Ricksten SE
Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420
[TBL] [Abstract][Full Text] [Related]
11. Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients.
Enomoto TM; Treggiari MM; Yanez ND; Merkel MJ
Respir Care; 2019 Jul; 64(7):743-751. PubMed ID: 30967439
[TBL] [Abstract][Full Text] [Related]
12. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
Schroeder RA; Rafii AA; Plotkin JS; Johnson LB; Rustgi VK; Kuo PC
Transplantation; 2000 Aug; 70(3):548-50. PubMed ID: 10949204
[TBL] [Abstract][Full Text] [Related]
13. Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives.
Bratel T; Lagerstrand L; Brodin LA; Nowak J; Randmaa I
Chest; 2005 Dec; 128(6 Suppl):615S-616S. PubMed ID: 16373868
[No Abstract] [Full Text] [Related]
14. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
15. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Wang A; Bashore TM
Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
[No Abstract] [Full Text] [Related]
16. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
17. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Barry PW
Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
[No Abstract] [Full Text] [Related]
18. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Administration of Inhaled Epoprostenol and Inhaled Milrinone in Extubated, Spontaneously Breathing Patients With Right Ventricular Failure and Portal Hypertension: A Report of 2 Cases.
Couture EJ; Tremblay JA; Elmi-Sarabi M; Lamarche Y; Denault AY
A A Pract; 2019 Mar; 12(6):208-211. PubMed ID: 30216198
[TBL] [Abstract][Full Text] [Related]
20. Refractory Cardiogenic Shock from Right Ventricular Infarction Successfully Managed with Inhaled Epoprostenol.
Held N; Little N; Krantz MJ; Stauffer BL
Am J Case Rep; 2017 Mar; 18():271-275. PubMed ID: 28298620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
